Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Saved in:
Bibliographic Details
Title: Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.
Authors: La Starza R; Universitá degli Studi di Perugia, Perugia, Italy., Cambò B; Universitá degli Studi di Perugia, Perugia, Italy., Pierini A; Universitá degli Studi di Perugia, Perugia, Italy., Bornhauser B; Universitá degli Studi di Perugia, Perugia, Italy., Montanaro A; Universitá degli Studi di Perugia, Perugia, Italy., Bourquin JP; Universitá degli Studi di Perugia, Perugia, Italy., Mecucci C; Universitá degli Studi di Perugia, Perugia, Italy., Roti G; Universitá degli Studi di Perugia, Perugia, Italy.
Source: JCO precision oncology [JCO Precis Oncol] 2019 Sep 20; Vol. 3. Date of Electronic Publication: 2019 Sep 20 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO.19.00172